# Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

> **NCT06152861** · PHASE2 · UNKNOWN · sponsor: **Glaukos Corporation** · enrollment: 250 (estimated)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost Ophthalmic Topical Cream low-dose
- **DRUG:** Travoprost Ophthalmic Topical Cream mid-dose
- **DRUG:** Travoprost Ophthalmic Topical Cream high-dose
- **DRUG:** Timolol maleate ophthalmic solution, 0.5%
- **DRUG:** Travoprost Ophthalmic Solution, 0.004%

## Key facts

- **NCT ID:** NCT06152861
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-15
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06152861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06152861, "Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06152861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*